PIA
CMRX

Piedmont Investment Advisors’s Chimerix, Inc. CMRX Stock Holding History

Piedmont Investment Advisors’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-765
Closed -$4K – 2358
2018
Q2 		$4K Buy
+765
New +$3.66K ﹤0.01% 2287

Other funds holding CMRX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Piedmont Investment Advisors's CMRX Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Chimerix, Inc. (CMRX) in Q3 2018, closing a stake of 765 shares — an estimated $4K sold.

Piedmont Investment Advisors first reported a position in CMRX in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 89 funds tracked by Wall St. Rank hold CMRX as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Chimerix, Inc. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 765 Chimerix, Inc. shares in Q3 2018, an estimated $4K.
  • Piedmont Investment Advisors first reported a position in Chimerix, Inc. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Chimerix, Inc. position peaked at $4K in Q2 2018.
  • 89 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.